Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Algernon Pharmaceuticals Inc AGNPF


Primary Symbol: C.AGN

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Recent & Breaking News (CSE:AGN)

Bigtincan Named SIIA Business Technology CODiE Award Finalist for Best Sales Enablement Platform

Business Wire July 13, 2017

Advancements in the early detection of life threatening diseases

Stockhouse Editorial March 17, 2017

Breathtec BioMedical CTO Delivers Presentation to International Science Community

Marketwired March 17, 2017

Breathtec Biomedical Provides Corporate Overview

Marketwired March 1, 2017

Breathtec BioMedical Attends BC Ministers Trade Mission to Israel and Announces Approval of Clinical Trials

Marketwired December 19, 2016

Successful Completion of Private Placement

Marketwired November 28, 2016

Breathtec BioMedical Announces Private Placement

Marketwired October 18, 2016

Breathtec BioMedical Provides Corporate Overview

Marketwired October 17, 2016

Breathtec BioMedical Presents Point-of-Care Strategy at International Breath Research Conference

Marketwired October 3, 2016

Breathtec Biomedical Engages DTG Partners to Advance Product Commercialization

Marketwired September 27, 2016

Breathtec BioMedical to Present at 2016 International Association of Breath Research

Marketwired September 8, 2016

Breathtec Biomedical Closes License of NA-NOSE Technology for Disease Detection

Marketwired May 24, 2016

Breathtec Biomedical Announces Prof. Hossam Haick as Consultant

Marketwired April 19, 2016

Breathtec Biomedical In-Licenses Advanced Stage Breath Analysis Technology

Marketwired April 13, 2016

Breathtec Biomedical Provides Update on Lead Project and In-Licensing Discussions

Marketwired April 4, 2016

Breathtec Biomedical Appoints Experienced Product Development and Regulatory Consultant

Marketwired February 22, 2016

CSE New Listing - Breathtec Biomedical Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

Newsfile February 2, 2016

The Daily Screed: Google most valuable company on earth, US Steel one of saddest

Chris Parry February 1, 2016

UPDATE - Breathtec Biomedical Commences Trading on the Canadian Securities Exchange (CSE: BTH)

Marketwired February 1, 2016